If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
462.60    -5.00 (-1.07%)
Bid:
465.80
Ask:
466.40
Spread: 0.60 (0.129%)
Market Cap: £2.37b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Total Voting Rights

28 Jun 2024 12:45

RNS Number : 3989U
QinetiQ Group plc
28 June 2024
 

QinetiQ Group plc

 

Total Voting Rights

 

28 June 2024 - In accordance with the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rule 5.6.1R, QinetiQ Group plc ("the Company") notifies the market that as of 28 June 2024 the Company's issued ordinary share capital consists of 573,320,788 ordinary shares of one penny each. There are no shares held in treasury. 

 

Therefore, the total number of voting rights in the Company is 573,320,788. This figure may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

About QinetiQ:

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

 

For further information, please contact:

Stephen Lamacraft, Interim Group Investor Relations Director: +44 (0) 7920 545841

Lindsay Walls, Group Director Communications: +44 (0) 7793 427582

James Field, Company Secretary: +44 (0) 7841 662957

 

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBBGDLDXDDGSI
Date   Source Headline
21st Sep 20203:57 pmRNSDirectorate Change
10th Sep 202010:29 amRNSDirector/PDMR Shareholding
20th Aug 20202:14 pmRNSHolding(s) in Company
13th Aug 20204:47 pmRNSDirector/PDMR Shareholding
11th Aug 202011:56 amRNSDirector/PDMR Shareholding
10th Aug 202011:28 amRNSTotal Voting Rights
4th Aug 20203:59 pmRNSBlock Listing Application
31st Jul 202012:50 pmRNSTransfer of Treasury Shares & Total Voting Rights
14th Jul 20202:00 pmRNSResult of Annual General Meeting
14th Jul 20207:00 amRNSQ1 Trading Update and Acquisition of Naimuri
13th Jul 20203:51 pmRNSQinetiQ enters next phase of growth in the US
10th Jul 202011:52 amRNSDirector/PDMR Shareholding
1st Jul 202010:50 amRNSDirector/PDMR Shareholding
1st Jul 202010:49 amRNSTotal Voting Rights
1st Jul 202010:46 amRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSDisposal of Boldon James to HelpSystems
23rd Jun 202011:46 amRNSDirector/PDMR Shareholding
12th Jun 202010:48 amRNSAnnual Financial Report
10th Jun 202012:31 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSPreliminary Results
19th May 20204:05 pmRNSDirectorate Change
12th May 202011:22 amRNSDirector/PDMR Shareholding
1st May 202011:16 amRNSBlock listing Interim Review
30th Apr 20207:00 amRNSAppointment of Broker
29th Apr 20204:17 pmRNSHolding(s) in Company
15th Apr 202010:35 amRNSDirector/PDMR Shareholding
1st Apr 20209:33 amRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading and COVID-19 update
20th Mar 202010:21 amRNSDirector/PDMR Shareholding
18th Mar 20202:13 pmRNSHolding(s) in Company
10th Mar 202011:13 amRNSDirector/PDMR Shareholding
11th Feb 202010:53 amRNSDirector/PDMR Shareholding
10th Feb 202012:14 pmRNSDirector/PDMR Shareholding
6th Feb 20209:40 amRNSHolding(s) in Company
4th Feb 20207:00 amRNSThird Quarter Trading Update
13th Jan 202012:09 pmRNSDirector/PDMR Shareholding
20th Dec 20191:24 pmRNSQinetiQ completes acquisition of MTEQ
10th Dec 20199:48 amRNSDirector/PDMR Shareholding
9th Dec 20199:04 amRNSHolding(s) in Company
28th Nov 20199:25 amRNSHolding(s) in Company
14th Nov 20197:00 amRNSInterim Results
12th Nov 201911:59 amRNSDirector/PDMR Shareholding
1st Nov 20199:30 amRNSBlock listing Interim Review
10th Oct 201911:37 amRNSDirector/PDMR Shareholding
2nd Oct 20197:00 amRNSQinetiQ acquisition of MTEQ
10th Sep 201912:06 pmRNSDirector/PDMR Shareholding
2nd Sep 201910:38 amRNSDirector/PDMR Shareholding
16th Aug 20191:35 pmRNSHolding(s) in Company
12th Aug 201912:35 pmRNSDirector/PDMR Shareholding
24th Jul 201912:11 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.